335 related articles for article (PubMed ID: 20421698)
1. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients.
Le Bastard N; Leurs J; Blomme W; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2010; 21(1):291-301. PubMed ID: 20421698
[TBL] [Abstract][Full Text] [Related]
2. No correlation between time-linked plasma and CSF Abeta levels.
Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.
Lewczuk P; Kornhuber J; Vanmechelen E; Peters O; Heuser I; Maier W; Jessen F; Bürger K; Hampel H; Frölich L; Henn F; Falkai P; Rüther E; Jahn H; Luckhaus Ch; Perneczky R; Schmidtke K; Schröder J; Kessler H; Pantel J; Gertz HJ; Vanderstichele H; de Meyer G; Shapiro F; Wolf S; Bibl M; Wiltfang J
Exp Neurol; 2010 Jun; 223(2):366-70. PubMed ID: 19664622
[TBL] [Abstract][Full Text] [Related]
5. Oral glucose loading modulates plasma β-amyloid level in alzheimer's disease patients: potential diagnostic method for Alzheimer's disease.
Takeda S; Sato N; Uchio-Yamada K; Yu H; Moriguchi A; Rakugi H; Morishita R
Dement Geriatr Cogn Disord; 2012; 34(1):25-30. PubMed ID: 22889768
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
[TBL] [Abstract][Full Text] [Related]
7. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J
Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876
[TBL] [Abstract][Full Text] [Related]
8. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.
Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M
J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274
[TBL] [Abstract][Full Text] [Related]
9. Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.
Takeda S; Sato N; Rakugi H; Morishita R
Mol Biosyst; 2010 Oct; 6(10):1760-6. PubMed ID: 20567751
[TBL] [Abstract][Full Text] [Related]
10. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
Lui JK; Laws SM; Li QX; Villemagne VL; Ames D; Brown B; Bush AI; De Ruyck K; Dromey J; Ellis KA; Faux NG; Foster J; Fowler C; Gupta V; Hudson P; Laughton K; Masters CL; Pertile K; Rembach A; Rimajova M; Rodrigues M; Rowe CC; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ward V; Martins RN; AIBL Research Group
J Alzheimers Dis; 2010; 20(4):1233-42. PubMed ID: 20413897
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid from Alzheimer's disease patients promotes amyloid beta-protein oligomerization.
Ikeda T; Ono K; Elashoff D; Condron MM; Noguchi-Shinohara M; Yoshita M; Teplow DB; Yamada M
J Alzheimers Dis; 2010; 21(1):81-6. PubMed ID: 20413863
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment.
Mamo JC; Jian L; James AP; Flicker L; Esselmann H; Wiltfang J
Ann Clin Biochem; 2008 Jul; 45(Pt 4):395-403. PubMed ID: 18583625
[TBL] [Abstract][Full Text] [Related]
13. Aminoterminally truncated and oxidized amyloid-β peptides in the cerebrospinal fluid of Alzheimer's disease patients.
Bibl M; Gallus M; Welge V; Esselmann H; Wiltfang J
J Alzheimers Dis; 2012; 29(4):809-16. PubMed ID: 22460324
[TBL] [Abstract][Full Text] [Related]
14. Blood-based neurochemical diagnosis of vascular dementia: a pilot study.
Bibl M; Esselmann H; Mollenhauer B; Weniger G; Welge V; Liess M; Lewczuk P; Otto M; Schulz JB; Trenkwalder C; Kornhuber J; Wiltfang J
J Neurochem; 2007 Oct; 103(2):467-74. PubMed ID: 17662050
[TBL] [Abstract][Full Text] [Related]
15. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
Hansson SF; Andréasson U; Wall M; Skoog I; Andreasen N; Wallin A; Zetterberg H; Blennow K
J Alzheimers Dis; 2009; 16(2):389-97. PubMed ID: 19221428
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
17. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
[TBL] [Abstract][Full Text] [Related]
18. Increased myeloperoxidase plasma levels in patients with Alzheimer's disease.
Tzikas S; Schlak D; Sopova K; Gatsiou A; Stakos D; Stamatelopoulos K; Stellos K; Laske C
J Alzheimers Dis; 2014; 39(3):557-64. PubMed ID: 24217274
[TBL] [Abstract][Full Text] [Related]
19. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.
Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
Neurobiol Aging; 2011 Aug; 32(8):1379-87. PubMed ID: 19781815
[TBL] [Abstract][Full Text] [Related]
20. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
